Longport, Inc. (LPTI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: May 22, 2025
Longport Revenue
Longport had revenue of $24.80K in the quarter ending September 30, 2005, a decrease of -98.19%. This brings the company's revenue in the last twelve months to $1.19M, down -40.46% year-over-year. In the year 2004, Longport had annual revenue of $2.46M with 391.06% growth.
Revenue (ttm)
1.19M
Revenue Growth
-40.46%
P/S Ratio
0.00
Revenue / Employee
148.31K
Employees
8
Market Cap
23.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2004 | 2.46M | 1.96M | 391.06% |
Dec 31, 2003 | 500.48K | 56.03K | 12.61% |
Dec 31, 2002 | 444.45K | 192.40K | 76.33% |
Dec 31, 2001 | 252.05K | -28.51K | -10.16% |
Dec 31, 2000 | 280.56K | -1.61M | -85.14% |
Dec 31, 1999 | Pro | Pro | Pro |
Dec 31, 1998 | Pro | Pro | Pro |
Dec 31, 1997 | Pro | Pro | Pro |
Dec 31, 1996 | Pro | Pro | Pro |
Dec 31, 1995 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Elite Pharmaceuticals | 70.00M |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
American Oncology Network | 1.76B |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |